To move Epitalon from experimental to evidence-based, several developments are essential: Randomized, double-blind, placebo-controlled clinical trials, ideally targeting specific endpoints (sleep, immune aging, telomere attrition) Toxicology and long-term safety studies, including exploration of stereoisomer effects and off-target consequences Validated delivery systems (e.g., dendrimer-conjugates, transdermal patches) that make real-world use feasible Pharmacodynamic biomarkers, to identify responders and track efficacy objectively over time Epitalon is not snake oil, but its also not a magic bullet
Thalassaemia gene therapy trial shows 'encouraging' results Scientists say they are "excited" by the results of a gene therapy trial for the inherited blood disorder beta-thalassaemia, which reduced the need for blood transfusions
Erectile dysfunction Clinical Knowledge Summary
NMN or NAD+: These molecules support cellular energy and work in tandem with antioxidants to maintain mitochondrial health
